Characterizing the site and mode of action of dynorphin at hippocampal mossy fiber synapses in the guinea pig.
Extracellular field potential recordings from the CA3 region in guinea pig hippocampal slices were used to study the release and action of dynorphin at the mossy fiber synapse. Dynorphin A(1-17) or U69593 inhibited mossy fiber synaptic responses in preparations in which the CA3 region was surgically isolated from the rest of the hippocampus. This inhibition was completely reversed by the kappa 1 selective antagonist nor-BNI, thus establishing the presence of functional kappa 1 receptors in CA3. Inhibitory effects of dynorphin on mossy fiber responses were unaltered in the presence of the N- or P-type Ca2+ channel blockers, omega-CgTx or omega-Aga IVA, respectively. This indicates that the action of dynorphin is independent of the particular type of Ca2+ channel that mediates transmitter release at the mossy fiber terminal. Heterosynaptic inhibition of mossy fiber responses was observed in the presence of nifedipine, omega-CgTx, or omega-Aga IVA, indicating that dynorphin release does not depend specifically on L-, N-, or P-type Ca2+ channels. The blockade of heterosynaptic inhibition by the membrane-permeant Ca2+ chelator EGTA-AM suggests the involvement of a slow Ca(2+)-dependent process in dynorphin release. On the basis of a variety of experimental evidence, we propose that the time course of heterosynaptic inhibition is determined primarily by the time course of clearance of dynorphin in the extracellular space.
Castillo
P E
PE
Department of Cellular and Molecular Pharmacology, University of California at San Francisco 94143-0450, USA.
Salin
P A
PA
Weisskopf
M G
MG
Nicoll
R A
RA
D000818:Animals; D002021:Buffers; D002118:Calcium / Q000378:metabolism; D015220:Calcium Channels / Q000502:physiology; D004399:Dynorphins / Q000378:metabolism / Q000494:pharmacology*; D006168:Guinea Pigs; D006624:Hippocampus / Q000187:drug effects* / Q000378:metabolism; D066298:In Vitro Techniques; D007425:Intracellular Membranes / Q000378:metabolism; D008959:Models, Neurological; D009412:Nerve Fibers / Q000187:drug effects*; D009433:Neural Inhibition; D017473:Receptors, Opioid, kappa / Q000378:metabolism; D013569:Synapses / Q000187:drug effects*; D013997:Time Factors
D002021:Buffers; D015220:Calcium Channels; D017473:Receptors, Opioid, kappa; D004399:Dynorphins; D002118:Calcium